Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
BMJ Open. 2022 Jan 25;12(1):e049300. doi: 10.1136/bmjopen-2021-049300.
BMJ Open. 2022.
PMID: 35078833
Free PMC article.
Cm-p5 Peptide Dimers Inhibit Biofilms of Candida albicans Clinical Isolates, C. parapsilosis and Fluconazole-Resistant Mutants of C. auris.
Amann V, Kissmann AK, Mildenberger V, Krebs I, Perez-Erviti JA, Martell-Huguet EM, Otero-Gonzalez AJ, Morales-Vicente F, Rodríguez-Castaño GP, Firacative C, Rodríguez A, Ständker L, Weil T, Spellerberg B, Stenger S, Rosenau F.
Amann V, et al. Among authors: mildenberger v.
Int J Mol Sci. 2023 Jun 6;24(12):9788. doi: 10.3390/ijms24129788.
Int J Mol Sci. 2023.
PMID: 37372935
Free PMC article.
Item in Clipboard
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S, Redaèlli M, Shukri A, Kentenich H, Simic D, Mildenberger V, Schmutzler R, Rhiem K, Stock S.
Kautz-Freimuth S, et al. Among authors: mildenberger v.
BMC Med Inform Decis Mak. 2023 Oct 16;23(1):223. doi: 10.1186/s12911-023-02327-9.
BMC Med Inform Decis Mak. 2023.
PMID: 37845719
Free PMC article.
Clinical Trial.
Item in Clipboard
The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity.
Mildenberger V, Alpízar-Pedraza D, Martell-Huguet EM, Krämer M, Bolotnikov G, Otero-Gonzalez AJ, Weil T, Rodriguez-Alfonso A, Preising N, Ständker L, Vogel V, Spellerberg B, Kissmann AK, Rosenau F.
Mildenberger V, et al.
Pharmaceuticals (Basel). 2024 Jan 9;17(1):83. doi: 10.3390/ph17010083.
Pharmaceuticals (Basel). 2024.
PMID: 38256916
Free PMC article.
Item in Clipboard
Cite
Cite